Hannah Deresiewicz

Head-Investor Relations at Kala Pharmaceuticals, Inc.

Hannah Deresiewicz

Hannah Deresiewicz

Head-Investor Relations at Kala Pharmaceuticals, Inc.

Biography

Hannah Deresiewicz occupies the position of Head-Investor Relations at Kala Pharmaceuticals, Inc. and Investor Relations Contact at Forty Seven, Inc. Ms. Deresiewicz is also Senior Associate at Stern Investor Relations, Inc.

Overview
RelSci Relationships

105

Contact Data
Trying to get in touch with Hannah Deresiewicz? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Hannah Deresiewicz likely has professional access to. A relationship does not necessarily indicate a personal connection.

Director at Stern Investor Relations, Inc.

Relationship likelihood: Strong

Senior Vice President at Stern Investor Relations, Inc.

Relationship likelihood: Strong

Senior Vice President at Stern Investor Relations, Inc.

Relationship likelihood: Strong

Vice President-Investor Relations & Communications at Kymera Therapeutics, Inc.

Relationship likelihood: Strong

Analyst at Stern Investor Relations, Inc.

Relationship likelihood: Strong

Chairman of the Board, President & Chief Executive Officer at Kala Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chief Accounting Officer, Chief Financial Officer & Treasurer at Kala Pharmaceuticals, Inc.

Relationship likelihood: Average

Chief Scientific Officer at Kala Pharmaceuticals, Inc.

Relationship likelihood: Average

Chief Medical Officer at Kala Pharmaceuticals, Inc.

Relationship likelihood: Average

Research Associate, Health Care Coverage & Access & Tracking Health System Performance at The Commonwealth Fund

Relationship likelihood: Average

Paths to Hannah Deresiewicz
Potential Connections via
Relationship Science
You
Hannah Deresiewicz
Head-Investor Relations at Kala Pharmaceuticals, Inc.
Career History
Professional
Tenure Unconfirmed

Blueprint Medicines Corp. is a precision therapy company. It focuses on medicines to improve the lives of patients with genomically defined cancers, rare diseases and cancer immunotherapy. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.

Head-Investor Relations
Current

Kala Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Watertown, MA.

Senior Associate
2013 - Current

Stern Investor Relations, Inc. provides investor relations services to healthcare and biotechnology companies. The company was founded in 2009 and is headquartered in New York, NY.

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Hannah Deresiewicz. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Hannah Deresiewicz's profile does not indicate a business or promotional relationship of any kind between RelSci and Hannah Deresiewicz.